Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.03500.0000 (0.00%)
At close: 01:12PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 3.59M
Enterprise value 2.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.31
Price/book (mrq)2.70
Enterprise value/revenue 2.35
Enterprise value/EBITDA -0.99

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-75.86%
S&P500 52-week change 3-15.89%
52-week high 30.1500
52-week low 30.0340
50-day moving average 30.0426
200-day moving average 30.0654

Share statistics

Avg vol (3-month) 330.85k
Avg vol (10-day) 391.8k
Shares outstanding 597.05M
Implied shares outstanding 6N/A
Float 851.56M
% held by insiders 131.77%
% held by institutions 112.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-51.99%
Return on equity (ttm)-97.50%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-747.18k
EBITDA -2.53M
Net income avi to common (ttm)-2.53M
Diluted EPS (ttm)-0.0320
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.17M
Total cash per share (mrq)0.02
Total debt (mrq)65.8k
Total debt/equity (mrq)4.82
Current ratio (mrq)4.75
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-2.23M
Levered free cash flow (ttm)-1.27M